Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Eva Cavallin-Ståhl"'
Autor:
Olof Ståhl, Stefan Arver, Eva Cavallin-Ståhl, Gabriella Cohn-Cedermark, Aleksander Giwercman, Karolina Bogefors, Jakob Eberhard, Yvonne Lundberg Giwercman
Publikováno v:
Asian Journal of Andrology, Vol 19, Iss 5, Pp 538-542 (2017)
Asian Journal of Andrology
Asian Journal of Andrology
Spermatogenesis is an androgen-regulated process that depends on the action of androgen receptor (AR). Sperm production may be affected in men treated for testicular cancer (TC), and it is important to identify the factors influencing the timing of s
Autor:
Gabriella Cohn-Cedermark, Rolf Wahlqvist, Olof Ståhl, Olbjørn Klepp, Ulf Håkansson, Torgrim Tandstad, Eva Cavallin-Ståhl
Publikováno v:
Scandinavian Journal of Urology. 50:9-13
The aim of this article is to present the Swedish and Norwegian Testicular Cancer Group (SWENOTECA), with an emphasis on the history of SWENOTECA, organization, results and current status.SWENOTECA was founded in 1981 as a binational organization ope
Autor:
Sven-Erik Olofsson, Eva Cavallin-Ståhl, Martin Neovius, Ingrid Glimelius, Sara Ekberg, Mats Jerkeman, Karin E. Smedby, Carina Nord, Gabriella Cohn Cedermark
Publikováno v:
Acta Oncologica; 54(10), pp 1770-1780 (2015)
Purpose. To investigate if testicular cancer survivors (TCSs) have a higher incidence of work loss compared with the population, accounting for stage, treatment and relapse.Material and methods. A cohort of 2146 Swedish TCSs diagnosed 1995–2007 (se
Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer
Autor:
Gabriella Cohn-Cedermark, Sigrid Isaksson, Stefan Arver, Olof Ståhl, Jakob Eberhard, Y. Lundberg Giwercman, Eva Cavallin-Ståhl, Aleksander Giwercman
Publikováno v:
Andrology. 2:252-258
Azoospermia is a serious potential side effect following treatment for testicular cancer (TC). Our purpose was to examine possible predictors of long-term azoospermia in TC survivors. Ejaculates and blood samples were obtained from 217 patients at po
Autor:
M. De Santis, Renske Altena, Friedemann Honecker, Leendert H. J. Looijenga, J. T. Hartmann, Aleksander Giwercman, R. de Wit, Silke Gillessen, Nicola Nicolai, Thomas Powles, Sophie D. Fosså, Giovanni Rosti, Robert Huddart, Alv A. Dahl, Gabriella Cohn-Cedermark, Jean-Pierre Lotz, Mark Schrader, M.P. Laguna, Gedske Daugaard, T. Tandstad, Richard Cathomas, S. Kliesch, Janine Nuver, Rainer Souchon, Jan Oldenburg, J. W. Oosterhuis, Alan Horwich, Roberto Salvioni, Frank Mayer, Martin Fenner, Andrea Necchi, S. Schweyer, C. Wittekind, Aude Flechon, Peter Albers, Susanne Krege, Jorge Aparicio, Carsten Bokemeyer, Noel W. Clarke, E. Rajpert-De Meyts, Jonas Busch, Klaus-Peter Dieckmann, Jörg Beyer, Axel Heidenreich, M. de Wit, K. Oechsle, U. De Giorgi, Aslam Sohaib, Jourik A. Gietema, Oliver Rick, Anja Lorch, C. Winter, Karim Fizazi, Felix Sedlmayer, Christian Kollmannsberger, J. R. Germá Lluch, Eva Cavallin-Ståhl, J. Claßen, Marcus Hentrich
Publikováno v:
Annals of Oncology, 24(4), 878-888. Elsevier Ltd.
Annals of Oncology
Annals of Oncology
In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands)
Autor:
Johan Linderoth, Eva Cavallin-Ståhl, Patrik Edén, Karin Rydström, Mats Ehinger, Mats Jerkeman, Patrick Joost
Publikováno v:
Leukemia & Lymphoma. 53:1764-1768
Immunohistochemical expression of CD40 is seen in 60-70% of diffuse large B-cell lymphoma (DLBCL) and is associated with a superior prognosis. By using gene expression profiling we aimed to further explore the underlying mechanisms for this effect. N
Autor:
Ulrika Stierner, Eva Cavallin-Ståhl, Roy M. Bremnes, Hege Sagstuen Haugnes, Anna Laurell, Gabriella Cohn-Cedermark, Olav Dahl
Publikováno v:
Acta Oncologica. 51:168-176
Background. The SWENOTECA IV protocol from 1995 is a prospective population-based study in metastatic non-seminomatous germ cell testicular cancer (NSGCT), designed for early identification of patients with poor response to standard cisplatin-based c
Autor:
Sven Erik Olofsson, Gabriella Cohn-Cedermark, Harald Anderson, Hans Wijkström, Olof Ståhl, Eva Cavallin-Ståhl, Roy M. Bremnes, Torgrim Tandstad, Mats Jerkeman, Arne Solberg, Olbjørn Klepp, Anna Laurell, Carl W. Langberg, Olav Dahl, Rolf Wahlqvist, Ulrika Stierner
Publikováno v:
Journal of Clinical Oncology. 29:2032-2039
Purpose From 1995 to 2003, 603 adult patients from Sweden and Norway with metastatic testicular nonseminomatous germ cell tumor (NSGCT) were included prospectively in a population-based protocol with strict guidelines for staging, treatment, and foll
Autor:
Thomas Wiebe, Thomas Relander, Yvonne Lundberg Giwercman, Christer Halldén, Patrik Romerius, Eva Cavallin-Ståhl, Aleksander Giwercman, Christian Moëll
Publikováno v:
Pharmacogenetics and Genomics. 21:263-269
OBJECTIVE: Cancer treatment in childhood leads to permanent azoospermia in a significant number of boys and those who are diagnosed with cancer before puberty do not have the option of pretreatment cryopreservation of spermatozoa. However, there is a
Autor:
Olof Ståhl, Yvonne Lundberg Giwercman, Thomas Relander, Patrik Romerius, Thomas Wiebe, Aleksander Giwercman, Eva Cavallin-Ståhl, Christian Moëll
Publikováno v:
International Journal of Andrology. 34:69-76
Childhood cancer survivors (CCS) have an increased risk of impaired spermatogenesis, but data regarding the disease- and treatment-related risk factors of azoospermia are scarce. Such information is crucial both for counselling CCS and for selecting